Cite
APA Citation
Moore, S., Atwal, S., Sachchithanantham, S., Streetly, M., Khan, I., Percy, L., Narat, S., D'Sa, S., Rabin, N., Johnston, R., Schey, S., & Yong, K. (n.d.). weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma. European journal of haematology, 90, 420–425. http://access.bl.uk/ark:/81055/vdc_100024491983.0x00001b